Skip to content
OpenCapital
Get started

Apimeds Pharmaceuticals US, Inc. APUS Q4 2024 earnings

Reported December 31, 2024

Diluted EPS-$0.02

Next report

Date not yet announced

Versus estimates

Diluted EPS

Q1 2026-$2.26Q3 2025-$0.14Q2 2025-$0.26Q1 2025-$0.05
Q4 2024-$0.02
Q3 2024-$0.03

Ask the moment Apimeds Pharmaceuticals US, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Apimeds Pharmaceuticals US, Inc. report Q4 2024 earnings?
Apimeds Pharmaceuticals US, Inc. (APUS) reported Q4 2024 earnings on December 31, 2024.
What were Apimeds Pharmaceuticals US, Inc.'s Q4 2024 revenue and EPS?
Apimeds Pharmaceuticals US, Inc. reported diluted EPS of $-0.02 for Q4 2024.